BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
read more
BlueRock Therapeutics Interviews Employee Reviews
All
Positive
Constructive
What did you like most about the interview process?
quick turnaround time - I heard back from the team in a timely manner
Review from Operations Dept
What would you improve about your company's interview process?
There aren't any Interviews reviews of BlueRock Therapeutics yet.
Be the first to contribute a review.
×